Pulse Biosciences
PLSE
$7.82
Share price
-2.86%
Change (1 day)
3.71%
Change (1 year)
Categories
Pulse Biosciences (PLSE) - Cash on Hand
Cash on Hand as of December 2023 : $44.36 M
According to Pulse Biosciences
's latest financial reports the company has $44.36 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Pulse Biosciences - Cash on Hand chart (from 2015 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $61.13 M | 113.67% |
| 2021-12-31 | $28.61 M | 39.75% |
| 2020-12-31 | $20.47 M | -19.38% |
| 2019-12-31 | $25.39 M | -57.37% |
| 2018-12-31 | $59.58 M | 56.51% |
| 2017-12-31 | $38.06 M | 132.2% |
| 2016-12-31 | $16.39 M | 354.66% |
| 2015-12-31 | $3.6 M | -48.55% |
| 2014-12-31 | $7 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 PAVmed
PAVM | $19.63 M | -55.73% | 🇺🇸 USA |
 Philips PHG | $2.06 B | 4,565.05% | 🇳🇱 Netherlands |